Clinical article · Acute care, Specialties

The first hour in acute ischaemic stroke: thrombolysis and thrombectomy eligibility

Written for
Hospital physicians, emergency doctors, stroke trainees and residents
Reading time
8 minutes
Published
Updated

Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.

Key points

  • The time last known well, not the time the symptoms were found, sets the treatment window.
  • Glucose is checked before anything else, and a suspected mimic should not delay treatment when stroke is the likely diagnosis.
  • Intravenous thrombolysis is standard within 4.5 hours; tenecteplase is a single-bolus alternative to alteplase.
  • Thrombectomy for large vessel occlusion is effective up to 24 hours in selected patients, so vessel imaging belongs in the first scan.
  • Anticoagulant use may rule out thrombolysis but does not rule out thrombectomy.

The clock and the first questions

Reperfusion treatment works best when it is given early. In an individual patient data meta-analysis of the alteplase trials, thrombolysis improved the chance of a good outcome across ages and stroke severities, and the benefit was greater the earlier it was given [2]. The first hour is therefore organised to reach a treatment decision quickly, following the national guideline, such as the 2026 AHA/ASA guideline [1], and the local stroke pathway.

  1. Establish the time last known well. For a patient who woke with symptoms, it is the time they were last seen normal.
  2. Check capillary glucose and treat hypoglycaemia.
  3. Score the NIHSS, and record baseline function and any anticoagulant with the time of the last dose.
  4. Image without delay: non-contrast CT to exclude haemorrhage, and CT angiography to look for a large vessel occlusion, with perfusion imaging where the pathway uses it.
  5. Decide on thrombolysis and on thrombectomy in parallel, not in sequence, and call the thrombectomy service early.

Door-to-needle time is measured in minutes; many services aim for well under an hour from arrival. Blood tests other than glucose should not delay thrombolysis unless a coagulopathy or anticoagulant use is suspected.

Mimics and chameleons

Hypoglycaemia, seizures with post-ictal weakness, migraine with aura, sepsis unmasking an old deficit, subdural haematoma, tumour and functional disorders can all imitate stroke. Thrombolysis given to a patient later found to have a mimic rarely causes symptomatic haemorrhage [11], so a reasonable suspicion of a mimic should not delay treatment when stroke remains the likely diagnosis. The reverse error is commoner: posterior circulation stroke presenting as dizziness, vomiting or confusion is easily missed.

Intravenous thrombolysis

Thrombolysis is standard within 4.5 hours of the time last known well when CT excludes haemorrhage and there is no contraindication [1]. Alteplase is given as 0.9 mg/kg (maximum 90 mg), with 10% as a bolus and the rest over 60 minutes. Tenecteplase, at 0.25 mg/kg (maximum 25 mg) as a single bolus, has been shown to be non-inferior to alteplase and is increasingly used [3, 4]. Blood pressure should be below 185/110 mmHg before treatment and kept below 180/105 mmHg for the next 24 hours.

SituationUsual approach
Haemorrhage on CTNo thrombolysis
Onset unknown or on wakingConsider thrombolysis if MRI or perfusion imaging shows a recent, salvageable infarct [8]
Taking a DOACUsually no thrombolysis if taken recently; local policy on drug levels and reversal applies [9]
Taking warfarinThrombolysis only if the INR is below the threshold in the local protocol
Large vessel occlusionThrombolysis if eligible, without delaying thrombectomy

Contraindications also include recent major surgery, serious head injury or intracranial surgery, active bleeding, and severe uncontrolled hypertension. Many older relative contraindications have been narrowed, and the local protocol lists those that apply.

Thrombectomy

Endovascular thrombectomy for occlusion of the proximal anterior circulation improved outcomes across the diverse populations pooled from the five 2015 trials [5]. In the DAWN trial, patients with internal carotid or proximal middle cerebral artery occlusion last known well 6 to 24 hours earlier, and with a deficit disproportionately severe for the infarct volume, also benefited [6]. Trials have since included patients with large ischaemic cores [7], and thrombectomy is now standard care for selected anterior and posterior circulation occlusions [4].

  • Image the vessels at the first scan, from the aortic arch to the vertex, so an occlusion is found without a second trip to CT.
  • Refer to the thrombectomy service as soon as an occlusion is seen; transfer is not delayed to watch for a response to thrombolysis.
  • Record baseline function, because severe pre-existing disability changes the balance of benefit.
  • Follow the regional model: direct transfer to a thrombectomy centre or treatment at the nearest stroke unit first.

A worked example

A 74-year-old man has right hemiparesis and aphasia, last known well 3 hours 10 minutes ago, NIHSS 14, CT without haemorrhage, and takes rivaroxaban. He is inside the thrombolysis window, but recent rivaroxaban intake is usually a contraindication unless the local protocol allows treatment on the basis of the time since the last dose or a specific anti-Xa level [9]. An NIHSS of 14 with aphasia and hemiparesis makes a left middle cerebral artery occlusion likely, so CT angiography now and early referral for thrombectomy are the priorities: anticoagulation is not a contraindication to thrombectomy.

After reperfusion

  • No antiplatelet, anticoagulant or prophylactic heparin for 24 hours after thrombolysis, and not until repeat imaging excludes haemorrhage [1].
  • Frequent neurological and blood pressure observations; any deterioration, new headache or vomiting means stopping an infusion still running and repeating CT.
  • After successful thrombectomy, two randomised trials found that more intensive systolic targets led to worse functional outcomes than conventional targets [10, 12].
  • Watch for orolingual angioedema after alteplase, particularly in patients taking ACE inhibitors.
  • Screen swallowing before oral intake, and plan secondary prevention, including the timing of anticoagulation for atrial fibrillation.

Traps

  • Using the time symptoms were found instead of the time last known well.
  • Missing hypoglycaemia.
  • Waiting for routine blood results before thrombolysis.
  • Imaging the brain without the vessels, then repeating CT for angiography.
  • Ruling out reperfusion altogether because the patient is anticoagulated.
  • Overlooking posterior circulation stroke in a patient with acute vertigo or reduced consciousness.

How Sana Health helps

The Neurology and Stroke engine takes the time last known well, NIHSS, glucose, anticoagulant and imaging findings, and writes a localisation before anything else. It then sets out eligibility for thrombolysis and for thrombectomy against current time windows and contraindications, with the blood pressure targets before and after treatment and the 24-hour pause in antithrombotic treatment after thrombolysis. The report leads with the time-critical actions and cites stroke guidelines and trials retrieved from PubMed and ClinicalTrials.gov.

Questions

What is the alteplase dose for acute ischaemic stroke?

0.9 mg/kg up to a maximum of 90 mg, with 10% given as a bolus over one minute and the remainder infused over 60 minutes. Tenecteplase is given as a single bolus of 0.25 mg/kg, maximum 25 mg.

What blood pressure is needed before thrombolysis?

Below 185/110 mmHg before thrombolysis, then below 180/105 mmHg for the following 24 hours, using the intravenous agents in the local protocol.

Can thrombolysis be given if the time of onset is unknown?

Selected patients can be treated when MRI shows a diffusion-weighted lesion without a corresponding FLAIR change, or perfusion imaging shows salvageable tissue, according to the criteria adopted by the local stroke service.

References

  1. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association (opens in a new tab)Stroke, 2026
  2. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials (opens in a new tab)Lancet, 2014
  3. Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial (opens in a new tab)JAMA, 2024
  4. Advances in treatments for acute ischemic stroke (opens in a new tab)BMJ, 2025
  5. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials (opens in a new tab)Lancet, 2016
  6. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct (opens in a new tab)N Engl J Med, 2018
  7. Trial of Endovascular Thrombectomy for Large Ischemic Strokes (opens in a new tab)N Engl J Med, 2023
  8. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset (opens in a new tab)N Engl J Med, 2018
  9. Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis (opens in a new tab)Stroke, 2020
  10. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial (opens in a new tab)Lancet, 2022
  11. Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis (opens in a new tab)Stroke, 2015
  12. Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial (opens in a new tab)JAMA, 2023